These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29775417)

  • 1. Targeting histone methyltransferase enhancer of zeste homolog-2 inhibits renal epithelial-mesenchymal transition and attenuates renal fibrosis.
    Zhou X; Xiong C; Tolbert E; Zhao TC; Bayliss G; Zhuang S
    FASEB J; 2018 May; 32(11):fj201800237R. PubMed ID: 29775417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancer of Zeste Homolog 2 Inhibition Attenuates Renal Fibrosis by Maintaining Smad7 and Phosphatase and Tensin Homolog Expression.
    Zhou X; Zang X; Ponnusamy M; Masucci MV; Tolbert E; Gong R; Zhao TC; Liu N; Bayliss G; Dworkin LD; Zhuang S
    J Am Soc Nephrol; 2016 Jul; 27(7):2092-108. PubMed ID: 26701983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking the histone lysine 79 methyltransferase DOT1L alleviates renal fibrosis through inhibition of renal fibroblast activation and epithelial-mesenchymal transition.
    Liu L; Zou J; Guan Y; Zhang Y; Zhang W; Zhou X; Xiong C; Tolbert E; Zhao TC; Bayliss G; Zhuang S
    FASEB J; 2019 Nov; 33(11):11941-11958. PubMed ID: 31373855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of enhancer of zeste homolog 2 alleviates renal injury associated with hyperuricemia.
    Shi Y; Xu L; Tao M; Fang L; Lu J; Gu H; Ma S; Lin T; Wang Y; Bao W; Qiu A; Zhuang S; Liu N
    Am J Physiol Renal Physiol; 2019 Mar; 316(3):F488-F505. PubMed ID: 30566000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancer of zeste homolog 2 promotes renal fibrosis after acute kidney injury by inducing epithelial-mesenchymal transition and activation of M2 macrophage polarization.
    Zhou X; Chen H; Hu Y; Ma X; Li J; Shi Y; Tao M; Wang Y; Zhong Q; Yan D; Zhuang S; Liu N
    Cell Death Dis; 2023 Apr; 14(4):253. PubMed ID: 37029114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis.
    Shi Y; Tao M; Wang Y; Zang X; Ma X; Qiu A; Zhuang S; Liu N
    J Pathol; 2020 Jan; 250(1):79-94. PubMed ID: 31579944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-deazaneplanocin A protects against cisplatin-induced renal tubular cell apoptosis and acute kidney injury by restoration of E-cadherin expression.
    Ni J; Hou X; Wang X; Shi Y; Xu L; Zheng X; Liu N; Qiu A; Zhuang S
    Cell Death Dis; 2019 May; 10(5):355. PubMed ID: 31043583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting enhancer of zeste homolog 2 protects against acute kidney injury.
    Zhou X; Zang X; Guan Y; Tolbert T; Zhao TC; Bayliss G; Zhuang S
    Cell Death Dis; 2018 Oct; 9(11):1067. PubMed ID: 30341286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis.
    Zhang Q; Dong P; Liu X; Sakuragi N; Guo SW
    Sci Rep; 2017 Jul; 7(1):6804. PubMed ID: 28754964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancer of zeste homolog 2 modulates oxidative stress-mediated pyroptosis in vitro and in a mouse kidney ischemia-reperfusion injury model.
    Liu H; Chen Z; Weng X; Chen H; Du Y; Diao C; Liu X; Wang L
    FASEB J; 2020 Jan; 34(1):835-852. PubMed ID: 31914694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of EZH2 prevents acute respiratory distress syndrome (ARDS)-associated pulmonary fibrosis by regulating the macrophage polarization phenotype.
    Bao X; Liu X; Liu N; Zhuang S; Yang Q; Ren H; Zhao D; Bai J; Zhou X; Tang L
    Respir Res; 2021 Jul; 22(1):194. PubMed ID: 34217280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of MLL1-menin interaction attenuates renal fibrosis in obstructive nephropathy.
    Zou J; Yu C; Zhang C; Guan Y; Zhang Y; Tolbert E; Zhang W; Zhao T; Bayliss G; Li X; Ye Z; Zhuang S
    FASEB J; 2023 Jan; 37(1):e22712. PubMed ID: 36527439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical roles of SMYD2 lysine methyltransferase in mediating renal fibroblast activation and kidney fibrosis.
    Liu L; Liu F; Guan Y; Zou J; Zhang C; Xiong C; Zhao TC; Bayliss G; Li X; Zhuang S
    FASEB J; 2021 Jul; 35(7):e21715. PubMed ID: 34143514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological Changes Induced by TKS4 Deficiency Can Be Reversed by EZH2 Inhibition in Colorectal Carcinoma Cells.
    Jacksi M; Schad E; Tantos A
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EZH2 is involved in silencing of WNT5A during epithelial-mesenchymal transition of colon cancer cell line.
    Tao J; Shi L; Huang L; Shi H; Chen H; Wang Y; Wang T
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2211-2219. PubMed ID: 28748258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emodin ameliorates tubulointerstitial fibrosis in obstructed kidneys by inhibiting EZH2.
    Xu L; Gao J; Huang D; Lin P; Yao D; Yang F; Zhang Y; Yang X; Wu M; Ye C
    Biochem Biophys Res Commun; 2021 Jan; 534():279-285. PubMed ID: 33288199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total flavonoids from Smilax glabra Roxb blocks epithelial-mesenchymal transition and inhibits renal interstitial fibrosis by targeting miR-21/PTEN signaling.
    Luo Q; Cai Z; Tu J; Ling Y; Wang D; Cai Y
    J Cell Biochem; 2019 Mar; 120(3):3861-3873. PubMed ID: 30304552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells.
    Kikuchi J; Takashina T; Kinoshita I; Kikuchi E; Shimizu Y; Sakakibara-Konishi J; Oizumi S; Marquez VE; Nishimura M; Dosaka-Akita H
    Lung Cancer; 2012 Nov; 78(2):138-43. PubMed ID: 22925699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic network of EZH2/SFRP1/Wnt in the epithelial-mesenchymal transition of laryngeal carcinoma cells.
    Chen W; Wang HT; Ji JF; Wang ZY; Shi T; Wu MH; Yu PJ
    Neoplasma; 2022 May; 69(3):680-690. PubMed ID: 35400167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EZH2-inhibitor DZNep enhances apoptosis of renal tubular epithelial cells in presence and absence of cisplatin.
    Chen SQ; Li JQ; Wang XQ; Lei WJ; Li H; Wan J; Hu Z; Zou YW; Wu XY; Niu HX
    Cell Div; 2020; 15():8. PubMed ID: 32508971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.